Cleavable complex formation in Leishmania chagasi treated with anilinoacridines
- PMID: 7935616
- DOI: 10.1016/0166-6851(94)90110-4
Cleavable complex formation in Leishmania chagasi treated with anilinoacridines
Abstract
Anilinoacridines have recently been found to possess antiparasitic activity toward Leishmania, Trypanosoma, and Plasmodium species. These compounds have been examined for their ability to generate cleavable complex, the protein-associated DNA lesion characteristic of topoisomerase II involvement, in intact L. chagasi promastigotes. At cytotoxic concentrations, anilinoacridine compounds give cleavable complex in a whole cell assay which suggests that the drugs affect a nuclear topoisomerase II in the parasite. Linearization of kinetoplast DNA minicircles also occurs in parasites treated with anilinoacridines at similar concentrations. Exonuclease digestions reveal that the linearized minicircles are blocked at the 5' end but not at the 3' end, further implicating a kinetoplast topoisomerase II in the cleavage process. Interestingly, cytotoxic alkylaminoacridines did not stimulate the production of cleaved DNA in the same experiments. DNA binding experiments showed no apparent correlation between the affinity of the compounds for DNA and antileishmanial activity. Although multiple cytotoxic mechanisms are likely at work, these experiments suggest that topoisomerase II enzyme(s) are affected by antileishmanial anilinoacridines.
Similar articles
-
Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi.Antimicrob Agents Chemother. 1996 Mar;40(3):706-9. doi: 10.1128/AAC.40.3.706. Antimicrob Agents Chemother. 1996. PMID: 8851597 Free PMC article.
-
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.Antimicrob Agents Chemother. 2010 Feb;54(2):620-6. doi: 10.1128/AAC.01025-09. Epub 2009 Dec 14. Antimicrob Agents Chemother. 2010. PMID: 20008775 Free PMC article.
-
Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.Biochem Pharmacol. 2013 May 15;85(10):1433-40. doi: 10.1016/j.bcp.2013.02.024. Epub 2013 Mar 1. Biochem Pharmacol. 2013. PMID: 23466420
-
Drugs affecting trypanosome topoisomerases.Adv Pharmacol. 1994;29B:187-200. Adv Pharmacol. 1994. PMID: 8996608 Review. No abstract available.
-
Kinetoplast as a potential chemotherapeutic target of trypanosomatids.Curr Pharm Des. 2008;14(9):847-54. doi: 10.2174/138161208784041051. Curr Pharm Des. 2008. PMID: 18473834 Review.
Cited by
-
Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major.Antimicrob Agents Chemother. 2014;58(1):78-87. doi: 10.1128/AAC.00887-13. Epub 2013 Oct 14. Antimicrob Agents Chemother. 2014. PMID: 24126577 Free PMC article.
-
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.Int J Parasitol Drugs Drug Resist. 2014 Aug 24;4(3):326-37. doi: 10.1016/j.ijpddr.2014.07.006. eCollection 2014 Dec. Int J Parasitol Drugs Drug Resist. 2014. PMID: 25516844 Free PMC article. Review.
-
Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi.Antimicrob Agents Chemother. 1996 Mar;40(3):706-9. doi: 10.1128/AAC.40.3.706. Antimicrob Agents Chemother. 1996. PMID: 8851597 Free PMC article.
-
In vitro activities of 7-substituted 9-chloro and 9-amino-2-methoxyacridines and their bis- and tetra-acridine complexes against Leishmania infantum.Antimicrob Agents Chemother. 2003 Jan;47(1):174-80. doi: 10.1128/AAC.47.1.174-180.2003. Antimicrob Agents Chemother. 2003. PMID: 12499188 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources